There were significant improvements with flibanserin versus placebo in the mean ( SE ) changes in the number of SSEs ( 1.0 [ 0.1 ] vs 0.6 [ 0.1 ] ) , FSFI desire domain score ( 0.7 [ 0.1 ] vs 0.4 [ 0.1 ] ) , FSDS-R Item 13 score ( -0.8 [ 0.1 ] vs -0.6 [ 0.1 ] ) , FSDS-R total score ( -8.3 [ 0.6 ] vs -6.3 [ 0.6 ] ) , and FSFI total score ( 4.2 [ 0.4 ] vs 2.7 [ 0.4 ] ; all P < 0.01 ) .